{
    "name": "velmanase alfa",
    "comment": "Rx",
    "other_names": [
        "Lamzede",
        "velmanase alfa-tycv"
    ],
    "classes": [
        "Enzymes",
        "Metabolic"
    ],
    "source": "https://reference.medscape.com/drug/lamzede-velmanase-alfa-4000324",
    "pregnancy": {
        "common": [
            "Based on findings from animal reproduction studies, embryofetal harm may occur when administered to pregnant females",
            "No data are available on use in pregnant females to evaluate a drug-associated risk of major birth defects, miscarriage, or other adverse maternal or fetal outcomes",
            "Advise pregnant females of potential risk to the fetus",
            "Consider need for treatment, potential drug-related risks to the fetus, and potential adverse outcomes from untreated maternal disease to continue or discontinue treatment during pregnancy ",
            "Verify pregnancy status in females of reproductive potential "
        ],
        "specific": [
            {
                "type": "Contraception",
                "description": [
                    "Females of reproductive potential: Use effective contraception during treatment and for 14 days after last dose"
                ]
            },
            {
                "type": "Animal data",
                "description": [
                    "Major visceral malformations were observed in rats and rabbits when velmanase alfa was administered in pregnant rats and rabbits during organogenesis",
                    "These malformations were observed in rats at the highest dose level, at exposures that were ~7-fold the recommended dose in patients of 1 mg/kg",
                    "Malformations occurred at all dose levels in rabbits with the highest dose exposures ~2.5-fold the recommended patient dose of 1 mg/kg"
                ]
            }
        ]
    },
    "lactation": {
        "common": [
            "There are no data on the presence of velmanase alfa or its metabolite in either human or animal milk, effects on breastfed infants, or effects on milk production"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": [
                {
                    "type": "Severe hypersensitivity reactions ",
                    "description": [
                        "Treated patients have experienced hypersensitivity reactions, including anaphylaxis",
                        "Appropriate medical support measures, including cardiopulmonary resuscitation equipment, should be readily available during administration",
                        "If severe hypersensitivity reaction (eg, anaphylaxis) occurs, discontinue immediately and initiate appropriate treatment ",
                        "Consider a desensitization procedure in patients with severe hypersensitivity reaction"
                    ]
                }
            ]
        },
        "contraindicators": {
            "common": [
                "None"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Based on findings from animal reproduction studies, embryofetal harm when administered to pregnant females"
            ],
            "specific": [
                {
                    "type": "Infusion-related reactions",
                    "description": [
                        "Infusion-associated reactions (IARs) reported ",
                        "Symptoms include pyrexia, chills, erythema, vomiting, cough, urticaria, rash, and conjunctivitis",
                        "Similar symptoms were observed in adult and pediatric populations",
                        "Before administering, consider pretreating with antihistamines, antipyretics, and/or corticosteroids to reduce the risk of IARs",
                        "If a severe IAR occurs, discontinue immediately and initiate appropriate medical treatment; consider the risks and benefits of readministering following a severe IAR ",
                        "May rechallenge using slower infusion rates",
                        "Once the patient tolerates the infusion, may increase infusion rate to reach the recommended infusion rate",
                        "If a mild or moderate IAR occurs, consider slowing the infusion rate or temporarily withholding the dose "
                    ]
                },
                {
                    "type": "Hypersensitivity reactions",
                    "description": [
                        "Hypersensitivity reactions including anaphylaxis reported",
                        "Anaphylaxis and severe hypersensitivity signs and symptoms include cyanosis, hypotension, emesis, urticaria, erythema, facial swelling, pyrexia, and tremor",
                        "Before administration, consider pretreating with antihistamines, antipyretics, and/or corticosteroids",
                        "Ensure appropriate medical support measures, including cardiopulmonary resuscitation equipment, is readily available during administration",
                        "If a severe hypersensitivity reaction (eg, anaphylaxis) occurs, discontinue immediately and initiate appropriate medical treatment; consider the risks and benefits of readministering following severe hypersensitivity reactions (including anaphylaxis) ",
                        "Rechallenge using slower infusion rates",
                        "In patients with severe hypersensitivity reaction, consider desensitization measures",
                        "If infusion is tolerated, increase the rate to reach the recommended dosage",
                        "If a mild or moderate hypersensitivity reaction occurs, consider slowing the infusion rate or temporarily withholding the dose"
                    ]
                }
            ]
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Nasopharyngitis",
            "percent": "66"
        },
        {
            "name": "Pyrexia",
            "percent": "40"
        },
        {
            "name": "Headache",
            "percent": "33"
        },
        {
            "name": "Arthralgia",
            "percent": "20"
        },
        {
            "name": "Acute tonsillitis",
            "percent": "13"
        },
        {
            "name": "Urinary tract infection",
            "percent": "13"
        },
        {
            "name": "Eye pruritus",
            "percent": "13"
        },
        {
            "name": "Gastroenteritis",
            "percent": "13"
        },
        {
            "name": "Hypersensitivity",
            "percent": "13"
        },
        {
            "name": "Influenza",
            "percent": "13"
        },
        {
            "name": "Syncope",
            "percent": "13"
        },
        {
            "name": "Toothache",
            "percent": "13"
        },
        {
            "name": "Back pain",
            "percent": "13"
        },
        {
            "name": "Ear infection",
            "percent": "13"
        },
        {
            "name": "Cardiac disorders",
            "percent": null
        },
        {
            "name": "Aortic valve incompetence",
            "percent": null
        },
        {
            "name": "palpitations",
            "percent": null
        },
        {
            "name": "tachycardia",
            "percent": null
        },
        {
            "name": "Ear and labyrinth disorders",
            "percent": null
        },
        {
            "name": "Deafness",
            "percent": null
        },
        {
            "name": "Eye disorders",
            "percent": null
        },
        {
            "name": "Lacrimation increased",
            "percent": null
        },
        {
            "name": "Gastrointestinal disorders",
            "percent": null
        },
        {
            "name": "Odynophagia",
            "percent": null
        },
        {
            "name": "General disorders and administration site conditions",
            "percent": null
        },
        {
            "name": "Asthenia",
            "percent": null
        },
        {
            "name": "fatigue",
            "percent": null
        },
        {
            "name": "Infections and infestations",
            "percent": null
        },
        {
            "name": "Endocarditis",
            "percent": null
        },
        {
            "name": "staphylococcal infection",
            "percent": null
        },
        {
            "name": "bacterial disease carrier",
            "percent": null
        },
        {
            "name": "furuncle",
            "percent": null
        },
        {
            "name": "Metabolism and nutrition disorders",
            "percent": null
        },
        {
            "name": "Decreased appetite",
            "percent": null
        },
        {
            "name": "Musculoskeletal and connective tissue disorders",
            "percent": null
        },
        {
            "name": "Joint swelling",
            "percent": null
        },
        {
            "name": "joint warmth",
            "percent": null
        },
        {
            "name": "Nervous system disorders",
            "percent": null
        },
        {
            "name": "Ataxia",
            "percent": null
        },
        {
            "name": "nervous system disorder",
            "percent": null
        },
        {
            "name": "somnolence",
            "percent": null
        },
        {
            "name": "Psychiatric disorders",
            "percent": null
        },
        {
            "name": "Psychotic disorder",
            "percent": null
        },
        {
            "name": "agitation",
            "percent": null
        },
        {
            "name": "encopresis",
            "percent": null
        },
        {
            "name": "nervousness",
            "percent": null
        },
        {
            "name": "Respiratory",
            "percent": null
        },
        {
            "name": "thoracic",
            "percent": null
        },
        {
            "name": "and mediastinal disorders",
            "percent": null
        },
        {
            "name": "Pharyngeal edema",
            "percent": null
        },
        {
            "name": "wheezing",
            "percent": null
        },
        {
            "name": "Skin",
            "percent": null
        },
        {
            "name": "subcutaneous tissue disorders",
            "percent": null
        },
        {
            "name": "Angioedema",
            "percent": null
        },
        {
            "name": "Vascular disorders",
            "percent": null
        },
        {
            "name": "Vascular fragility",
            "percent": null
        },
        {
            "name": "hypotension",
            "percent": null
        }
    ]
}